JG
AVNR

Jefferies Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Jefferies Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,521,986
Closed -$25.8M – 2654
2014
Q4 		$25.8M Sell
1,521,986
-5,679,083
-79% -$79.9M 0.15% 117
2014
Q3 		$85.8M Buy
7,201,069
+7,200,018
+685,064% +$49.2M 0.59% 27
2014
Q2 		$6K Buy
+1,051
New +$4.84K ﹤0.01% 2006

Jefferies Group's AVNR Position: Q1 2015 in Review

Jefferies Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,521,986 shares — an estimated $25.8M sold.

Jefferies Group first reported a position in AVNR in Q2 2014 and held it in 3 quarters. The position peaked at $85.8M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Jefferies Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Jefferies Group sold 1,521,986 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $25.8M.
  • Jefferies Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 3 quarters.
  • Jefferies Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $85.8M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Jefferies Group's 13F filing for Q1 2015, filed 18 May 2015.